# A Clinical Trial of Mass Balance of [14C] TQ05105 in Healthy Chinese Subjects

> **NCT07293390** · PHASE1 · COMPLETED · sponsor: **Chia Tai Tianqing Pharmaceutical Group Co., Ltd.** · enrollment: 6 (actual)

## Conditions studied

- Mass Balance of [14C] TQ05105 in Healthy Chinese Subjects

## Interventions

- **DRUG:** TQ05105

## Key facts

- **NCT ID:** NCT07293390
- **Lead sponsor:** Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-03-18
- **Primary completion:** 2024-04-08
- **Final completion:** 2024-08-20
- **Target enrollment:** 6 (ACTUAL)
- **Last updated:** 2025-12-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07293390

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07293390, "A Clinical Trial of Mass Balance of [14C] TQ05105 in Healthy Chinese Subjects". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT07293390. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*